These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
389 related articles for article (PubMed ID: 26674214)
1. Peripheral sub-inflammation is associated with antidepressant consumption in schizophrenia. Results from the multi-center FACE-SZ data set. Fond G; Godin O; Brunel L; Aouizerate B; Berna F; Bulzacka E; Capdevielle D; Chereau I; Dorey JM; Dubertret C; Dubreucq J; Faget C; Gabayet F; Le Strat Y; Micoulaud-Franchi JA; Misdrahi D; Rey R; Richieri R; Passerieux C; Schandrin A; Schürhoff F; Tronche AM; Urbach M; Vidalhet P; Llorca PM; Leboyer M; J Affect Disord; 2016 Feb; 191():209-15. PubMed ID: 26674214 [TBL] [Abstract][Full Text] [Related]
2. Abnormal C-reactive protein blood levels as a specific biomarker of major depression and non-remission under antidepressants in schizophrenia. Fond G; Micoulaud-Franchi JA; Faugere M; Boyer L; Faget-Agius C; Lançon C; Richieri R; Cermolacce M Prog Neuropsychopharmacol Biol Psychiatry; 2020 Mar; 97():109800. PubMed ID: 31676465 [TBL] [Abstract][Full Text] [Related]
3. Relationships between low-grade peripheral inflammation and psychotropic drugs in schizophrenia: results from the national FACE-SZ cohort. Fond G; Resseguier N; Schürhoff F; Godin O; Andrianarisoa M; Brunel L; Bulzacka E; Aouizerate B; Berna F; Capdevielle D; Chereau I; D'Amato T; Dubertret C; Dubreucq J; Faget C; Gabayet F; Lançon C; Llorca PM; Mallet J; Misdrahi D; Passerieux C; Rey R; Schandrin A; Urbach M; Vidailhet P; Boyer L; Leboyer M; Eur Arch Psychiatry Clin Neurosci; 2018 Sep; 268(6):541-553. PubMed ID: 29127503 [TBL] [Abstract][Full Text] [Related]
5. High C-reactive protein levels are associated with depressive symptoms in schizophrenia. Faugere M; Micoulaud-Franchi JA; Faget-Agius C; Lançon C; Cermolacce M; Richieri R J Affect Disord; 2018 Jan; 225():671-675. PubMed ID: 28917193 [TBL] [Abstract][Full Text] [Related]
6. Remission of depression in patients with schizophrenia and comorbid major depressive disorder: results from the FACE-SZ cohort. Fond G; Boyer L; Berna F; Godin O; Bulzacka E; Andrianarisoa M; Brunel L; Aouizerate B; Capdevielle D; Chereau I; Coulon N; D'Amato T; Dubertret C; Dubreucq J; Faget C; Leignier S; Lançon C; Mallet J; Misdrahi D; Passerieux C; Rey R; Schandrin A; Urbach M; Vidailhet P; Leboyer M; Schürhoff F; Llorca PM; Br J Psychiatry; 2018 Aug; 213(2):464-470. PubMed ID: 29871707 [TBL] [Abstract][Full Text] [Related]
7. Birth by cesarean section and schizophrenia: results from the multicenter FACE-SZ data-set. Fond G; Bulzacka E; Boyer L; Llorca PM; Godin O; Brunel L; Andrianarisoa MG; Aouizerate B; Berna F; Capdevielle D; Chereau I; Denizot H; Dorey JM; Dubertret C; Dubreucq J; Faget C; Gabayet F; Le Strat Y; Micoulaud-Franchi JA; Misdrahi D; Rey R; Richieri R; Roger M; Passerieux C; Schandrin A; Urbach M; Vidalhet P; Schürhoff F; Leboyer M; Eur Arch Psychiatry Clin Neurosci; 2017 Sep; 267(6):587-594. PubMed ID: 27349652 [TBL] [Abstract][Full Text] [Related]
8. Chronic Peripheral Inflammation is Associated With Cognitive Impairment in Schizophrenia: Results From the Multicentric FACE-SZ Dataset. Bulzacka E; Boyer L; Schürhoff F; Godin O; Berna F; Brunel L; Andrianarisoa M; Aouizerate B; Capdevielle D; Chéreau-Boudet I; Chesnoy-Servanin G; Danion JM; Dubertret C; Dubreucq J; Faget C; Gabayet F; Le Gloahec T; Llorca PM; Mallet J; Misdrahi D; Rey R; Richieri R; Passerieux C; Roux P; Yazbek H; Leboyer M; Fond G; Schizophr Bull; 2016 Sep; 42(5):1290-302. PubMed ID: 27143795 [TBL] [Abstract][Full Text] [Related]
9. Chronic low-grade peripheral inflammation is associated with severe nicotine dependence in schizophrenia: results from the national multicentric FACE-SZ cohort. Fond G; Berna F; Andrianarisoa M; Godin O; Leboyer M; Brunel L; Aouizerate B; Capdevielle D; Chereau I; D'Amato T; Denizot H; Dubertret C; Dubreucq J; Faget C; Gabayet F; Llorca PM; Mallet J; Misdrahi D; Passerieux C; Richieri R; Rey R; Schandrin A; Urbach M; Vidailhet P; Boyer L; Schürhoff F; Eur Arch Psychiatry Clin Neurosci; 2017 Aug; 267(5):465-472. PubMed ID: 28238173 [TBL] [Abstract][Full Text] [Related]
10. Hypovitaminosis D is associated with negative symptoms, suicide risk, agoraphobia, impaired functional remission, and antidepressant consumption in schizophrenia. Fond G; Faugere M; Faget-Agius C; Cermolacce M; Richieri R; Boyer L; Lançon C Eur Arch Psychiatry Clin Neurosci; 2019 Dec; 269(8):879-886. PubMed ID: 30078128 [TBL] [Abstract][Full Text] [Related]
11. Associations of high sensitivity C-reactive protein levels in schizophrenia and comparison groups. Joseph J; Depp C; Martin AS; Daly RE; Glorioso DK; Palmer BW; Jeste DV Schizophr Res; 2015 Oct; 168(1-2):456-60. PubMed ID: 26341579 [TBL] [Abstract][Full Text] [Related]
12. Elevated C-reactive protein levels and metabolic syndrome in the elderly: The role of central obesity data from the InChianti study. Zuliani G; Volpato S; Galvani M; Blè A; Bandinelli S; Corsi AM; Lauretani F; Maggio M; Guralnik JM; Fellin R; Ferrucci L Atherosclerosis; 2009 Apr; 203(2):626-32. PubMed ID: 18845301 [TBL] [Abstract][Full Text] [Related]
13. Redefining peripheral inflammation signature in schizophrenia based on the real-world FACE-SZ cohort. Fond G; Sunhary de Verville PL; Richieri R; Etchecopar-Etchart D; Korchia T; Faugere M; Godin O; Schürhoff F; Berna F; Aouizerate B; Capdevielle D; Chereau I; Clauss-Kobayashi J; Coulon N; Dorey JM; Dubertret C; Dubreucq J; Mallet J; Misdrahi D; Passerieux C; Pignon B; Rey R; Urbach M; Leboyer M; Prog Neuropsychopharmacol Biol Psychiatry; 2021 Dec; 111():110335. PubMed ID: 33933539 [TBL] [Abstract][Full Text] [Related]
14. [The 10-year findings from the FondaMental Academic Center of Expertise for Schizophrenia (FACE-SZ): Review and recommendations for clinical practice]. Schürhoff F; Fond G; Berna F; Bulzacka E; Godin O; Boyer L; Misdrahi D; Andrianarisoa M; Brunel L; Coulon N; Aouizerate B; Capdevielle D; Chereau I; D'Amato T; Dubertret C; Dubreucq J; Faget C; Gabayet F; Mallet J; Rey R; Lancon C; Passerieux C; Schandrin A; Urbach M; Vidailhet P; Leboyer M; Llorca PM; Encephale; 2019 Feb; 45(1):9-14. PubMed ID: 30327207 [TBL] [Abstract][Full Text] [Related]
15. Hypovitaminosis D is associated with depression and anxiety in schizophrenia: Results from the national FACE-SZ cohort. Fond G; Godin O; Schürhoff F; Berna F; Bulzacka E; Andrianarisoa M; Brunel L; Aouizerate B; Capdevielle D; Chereau I; Coulon N; D'Amato T; Dubertret C; Dubreucq J; Faget C; Lançon C; Leignier S; Mallet J; Misdrahi D; Passerieux C; Rey R; Schandrin A; Urbach M; Vidailhet P; Leboyer M; Boyer L; Llorca PM; Psychiatry Res; 2018 Dec; 270():104-110. PubMed ID: 30245372 [TBL] [Abstract][Full Text] [Related]
16. Sex differences in the association of baseline c-reactive protein (CRP) and acute-phase treatment outcomes in major depressive disorder: Findings from the EMBARC study. Jha MK; Minhajuddin A; Chin-Fatt C; Greer TL; Carmody TJ; Trivedi MH J Psychiatr Res; 2019 Jun; 113():165-171. PubMed ID: 30959227 [TBL] [Abstract][Full Text] [Related]
17. Baseline serum C-reactive protein levels may predict antidepressant treatment responses in patients with major depressive disorder. Zhang J; Yue Y; Thapa A; Fang J; Zhao S; Shi W; Yang Z; Li Y; Yuan Y J Affect Disord; 2019 May; 250():432-438. PubMed ID: 30878656 [TBL] [Abstract][Full Text] [Related]
18. Association between C-reactive protein (CRP) with depression symptom severity and specific depressive symptoms in major depression. Köhler-Forsberg O; Buttenschøn HN; Tansey KE; Maier W; Hauser J; Dernovsek MZ; Henigsberg N; Souery D; Farmer A; Rietschel M; McGuffin P; Aitchison KJ; Uher R; Mors O Brain Behav Immun; 2017 May; 62():344-350. PubMed ID: 28257825 [TBL] [Abstract][Full Text] [Related]
19. Self-reported pain in patients with schizophrenia. Results from the national first-step FACE-SZ cohort. Fond G; Boyer L; Andrianarisoa M; Godin O; Bulzacka E; Berna F; Brunel L; Coulon N; Aouizerate B; Capdevielle D; Chereau I; D'amato T; Denizot H; Dubertret C; Dubreucq J; Faget C; Leignier S; Mallet J; Misdrahi D; Rey R; Lancon C; Passerieux C; Schandrin A; Urbach M; Vidailhet P; Leboyer M; Schurhoff F; Llorca PM; Prog Neuropsychopharmacol Biol Psychiatry; 2018 Jul; 85():62-68. PubMed ID: 29678770 [TBL] [Abstract][Full Text] [Related]
20. Medication and aggressiveness in real-world schizophrenia. Results from the FACE-SZ dataset. Fond G; Boyer L; Favez M; Brunel L; Aouizerate B; Berna F; Capdevielle D; Chereau I; Dorey JM; Dubertret C; Dubreucq ; Faget C; Gabayet F; Laouamri H; Lancon C; Le Strat Y; Misdrahi D; Rey R; Passerieux C; Schandrin A; Schurhoff F; Tronche AM; Urbach M; Vidalhet P; Llorca PM; Pelissolo A; Psychopharmacology (Berl); 2016 Feb; 233(4):571-8. PubMed ID: 26630993 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]